<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Batchelor | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/dewangle01/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/dewangle01/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Batchelor.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">cd8bc02010619266bf0f354277eb1c46</guid>
				<title>Batchelor posted an update: One Complete Syntheses of Rhamnofolane, Tigliane, and also [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42769/</link>
				<pubDate>Sun, 09 Feb 2025 11:18:46 -0800</pubDate>

									<content:encoded><![CDATA[<p>One Complete Syntheses of Rhamnofolane, Tigliane, and also Daphnane Diterpenoids.</p>
<p>PET with 18F-fluorodeoxyglucose (FDG) is used to assess a wide array of inflammatory and neoplastic disorders. FDG-PET has shown particular utility in the evaluation of disorders of the central nervous system (CNS). Although fused PET/computed tomography (CT) is&hellip;<span class="activity-read-more" id="activity-read-more-42769"><a href="http://www.nationalboardinstitute.com/activity/p/42769/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1b34da93c7ae3007d8ba75bbcc1caf94</guid>
				<title>Batchelor posted an update: To evaluate the potency of potential helicase modulators, we [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41861/</link>
				<pubDate>Sat, 08 Feb 2025 11:21:13 -0800</pubDate>

									<content:encoded><![CDATA[<p>To evaluate the potency of potential helicase modulators, we developed an assay of helicase enzyme activity. Using a DNA or RNA biotin labelled oligonucleotide and after the addition of a recombinant helicase, the nucleic acid unwinds, causing the emission of luminescence, which is quantified with a particular antibody. In our assay, one of the&hellip;<span class="activity-read-more" id="activity-read-more-41861"><a href="http://www.nationalboardinstitute.com/activity/p/41861/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">504fb675a3e671ad5e15466d506a245d</guid>
				<title>Batchelor posted an update: FBXO16-mediated hnRNPL ubiquitination and also wreckage [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40081/</link>
				<pubDate>Thu, 06 Feb 2025 12:59:34 -0800</pubDate>

									<content:encoded><![CDATA[<p>FBXO16-mediated hnRNPL ubiquitination and also wreckage performs a growth suppressant position within ovarian cancers.</p>
<p> Restoring miR-369 reversed the hyperphosphorylation of tau and downregulated Fyn and SRPK2. Additionally, miR-369 was shown to target the 3&#8217;UTRs of Fyn and SRPK2 to regulate their expression levels. Conclusion Loss of miR-369&hellip;<span class="activity-read-more" id="activity-read-more-40081"><a href="http://www.nationalboardinstitute.com/activity/p/40081/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ddeabd615b985b1c101ee42a4adffcdf</guid>
				<title>Batchelor posted an update: Conclusions The evaluation of a large patient cohort [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36512/</link>
				<pubDate>Sun, 02 Feb 2025 10:51:43 -0800</pubDate>

									<content:encoded><![CDATA[<p>Conclusions The evaluation of a large patient cohort provided a better understanding of the present epidemiology of CA in an outpatient hospital setting in Germany. An effective three-scale therapeutic regime and preventive measures were outlined. © 2020 The Author(s).The microstructures of the activated carbon black microparticles (ACBMPs)&hellip;<span class="activity-read-more" id="activity-read-more-36512"><a href="http://www.nationalboardinstitute.com/activity/p/36512/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">25b11f56de31225c29bd5fe670791117</guid>
				<title>Batchelor posted an update: This work described the development of a novel method for [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30054/</link>
				<pubDate>Tue, 28 Jan 2025 14:39:21 -0800</pubDate>

									<content:encoded><![CDATA[<p>This work described the development of a novel method for simultaneous extraction of eight active compounds (including catechin, albiflorin, paeoniflorin, ferulic acid, ginsenoside Rg1, tetrahydropalmatine, ginsenoside Rb1 and osthole) from Yaobitong capsule by accelerated solvent extraction (ASE). Response surface methodology (RSM) with&hellip;<span class="activity-read-more" id="activity-read-more-30054"><a href="http://www.nationalboardinstitute.com/activity/p/30054/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4d5a45cf3056f41ebf9ff0df2706ca5e</guid>
				<title>Batchelor became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30001/</link>
				<pubDate>Tue, 28 Jan 2025 14:35:13 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>